ArticleAsian Pacific journal of cancer prevention : APJCP2026
Diagnostic Accuracy and Reproducibility of ChatGPT-4o for HER2 Immunohistochemistry Scoring in Equivocal Breast Cancer Cases.
Article in Asian Pacific journal of cancer prevention : APJCP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHER2 immunohistochemistry (IHC) plays a central role in therapeutic decision-making for breast cancer. However, interpretation of equivocal (2+) IHC results remains challenging and is subject to interobserver variability, necessitating reflex in situ hybridization testing. This study evaluated the diagnostic performance and reproducibility of ChatGPT-4o, a general-purpose large language model, in scoring HER2 IHC in breast cancer cases initially classified as IHC 2+.
methodsWe retrospectively analyzed 81 formalin-fixed, paraffin-embedded invasive carcinoma of no special type (NST) cases with prior HER2 IHC 2+ scores and corresponding dual in situ hybridization (DISH) results. Five high-power field images per case were independently analyzed by ChatGPT-4o across three sessions, using a standardized prompt aligned with the ASCO/CAP 2023 guidelines. Cases remaining equivocal after AI-assisted interpretation were excluded from diagnostic performance calculations. HER2 DISH served as the reference standard.
resultsFourteen cases (17.3%) remained equivocal following AI interpretation. Among the 67 reclassified cases, ChatGPT-4o demonstrated an overall diagnostic accuracy of 79% (95% CI: 67-88%), a sensitivity of 30%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 77%. Intra-model reproducibility was good (intraclass correlation coefficient = 0.78), whereas agreement with HER2 DISH was fair (Cohen's κ = 0.375). Misclassification predominantly involved false-negative interpretations among HER2-positive cases.
conclusionChatGPT-4o demonstrated high specificity and reproducibility for identifying HER2 IHC 3+ cases but showed limited sensitivity and only fair concordance with HER2 DISH. These findings indicate that, in its current general-purpose form, ChatGPT-4o is not suitable for independent HER2 assessment and may serve, at best, as an exploratory adjunct to pathologist interpretation.
Indexed as
Identifiers
42169576What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.